Published in Am J Transplant on March 28, 2011
Challenging issues in tuberculosis in solid organ transplantation. Clin Infect Dis (2013) 2.27
Infectious disease transmission during organ and tissue transplantation. Emerg Infect Dis (2012) 1.45
Bacterial infection after liver transplantation. World J Gastroenterol (2014) 0.94
Histoplasmosis after solid organ transplant. Clin Infect Dis (2013) 0.92
Solid organ transplant-associated lymphocytic choriomeningitis, United States, 2011. Emerg Infect Dis (2012) 0.90
Guidelines for the assessment and acceptance of potential brain-dead organ donors. Rev Bras Ter Intensiva (2016) 0.81
Dengue Virus Transmission from Living Donor to Recipient in Liver Transplantation: A Case Report. J Clin Exp Hepatol (2016) 0.80
Preventable errors in organ transplantation: an emerging patient safety issue? Am J Transplant (2012) 0.79
The risk factors for tuberculosis in liver or kidney transplant recipients. BMC Infect Dis (2014) 0.79
Bloodstream infections after solid-organ transplantation. Virulence (2016) 0.79
NUTORC-a transdisciplinary health services and outcomes research team in transplantation. Transl Behav Med (2012) 0.78
Selecting suitable solid organ transplant donors: Reducing the risk of donor-transmitted infections. World J Transplant (2014) 0.78
Neoplastic disease after liver transplantation: Focus on de novo neoplasms. World J Gastroenterol (2015) 0.77
Endemic mycoses in immunocompromised hosts. Curr Infect Dis Rep (2013) 0.76
Urothelial carcinoma of donor origin in a kidney transplant patient. J Immunother Cancer (2016) 0.75
Hepatitis B transmission by cell and tissue allografts: how safe is safe enough? World J Gastroenterol (2014) 0.75
KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors. Transplantation (2017) 0.75
Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet (1984) 5.74
Pancreaticoduodenal transplantation in humans. Surg Gynecol Obstet (1984) 4.49
Heterotopic heart transplantation in the rat receiving FK-506 alone or with cyclosporine. Transplant Proc (1987) 4.21
Recombinant IL-12 administration induces tumor regression in association with IFN-gamma production. J Immunol (1994) 2.68
Treatment of fibrolamellar hepatoma with partial or total hepatectomy and transplantation of the liver. Surg Gynecol Obstet (1986) 2.07
Identification of bipotential progenitor cells in human liver development. Hepatology (1996) 1.84
The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children. Transplantation (1988) 1.72
Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. ASTS/ASTP EBV-PTLD Task Force and The Mayo Clinic Organized International Consensus Development Meeting. Transplantation (1999) 1.70
Significance of Aspergillus species isolated from respiratory secretions in the diagnosis of invasive pulmonary aspergillosis. J Clin Microbiol (1980) 1.64
Epstein-Barr virus-negative post-transplant lymphoproliferative disorders: a distinct entity? Am J Surg Pathol (2000) 1.56
Immunomodulation for intestinal transplantation by allograft irradiation, adjunct donor bone marrow infusion, or both. Transplantation (2000) 1.53
Hepatocyte paraffin 1: a monoclonal antibody that reacts with hepatocytes and can be used for differential diagnosis of hepatic tumors. Am J Pathol (1993) 1.33
A fresh look at augmenter of liver regeneration in rats. Hepatology (1999) 1.32
Comparative incidence of de novo nonlymphoid malignancies after liver transplantation under tacrolimus using surveillance epidemiologic end result data. Transplantation (1998) 1.28
Identification of bipotential progenitor cells in human liver regeneration. Lab Invest (1996) 1.26
Cancer immunotherapy of established tumors with IL-12. Effective delivery by genetically engineered fibroblasts. J Immunol (1995) 1.25
Utilization of hepatocyte-specific antibody in the immunocytochemical evaluation of liver tumors. Mod Pathol (1997) 1.22
Clonal analysis of transplant-associated lymphoproliferations based on the structure of the genomic termini of the Epstein-Barr virus. Blood (1988) 1.19
Liver-derived DEC205+B220+CD19- dendritic cells regulate T cell responses. J Immunol (2001) 1.18
Long-term results after liver transplantation for primary hepatic epithelioid hemangioendothelioma. Ann Surg Oncol (1995) 1.15
Immunomodulatory effects of inhaled carbon monoxide on rat syngeneic small bowel graft motility. Gut (2003) 1.12
Cholangiocarcinoma: delayed CT contrast enhancement patterns. Radiology (1997) 1.08
FK 506 ameliorates the hepatic injury associated with ischemia and reperfusion in rats. Hepatology (1991) 1.05
Extramedullary plasmacytoma of the head and neck: use of paraffin sections to assess clonality with in situ hybridization, growth fraction, and the presence of Epstein-Barr virus. Mod Pathol (1995) 1.02
Suppressed T-cell receptor zeta chain expression and cytokine production in pancreatic cancer patients. Clin Cancer Res (2001) 1.01
Oxygen free radical content and neutrophil infiltration are important determinants in mucosal injury after rat small bowel transplantation. Transplantation (1996) 0.99
Ex vivo application of carbon monoxide in University of Wisconsin solution to prevent intestinal cold ischemia/reperfusion injury. Am J Transplant (2006) 0.99
Posttransplant lymphoproliferative disorders in heart-lung transplant recipients: primary presentation in the allograft. Hum Pathol (1989) 0.99
Causes of death in autopsied liver transplantation patients. Mod Pathol (1998) 0.98
Characterization of ductular hepatocytes in primary liver allograft failure. Mod Pathol (1997) 0.97
In situ hybridization of albumin mRNA in normal liver and liver tumors: identification of hepatocellular origin. Virchows Arch B Cell Pathol Incl Mol Pathol (1993) 0.96
Infarcted regenerative nodules in cirrhosis: CT and MR imaging findings with pathologic correlation. AJR Am J Roentgenol (2000) 0.96
Highly active antiretroviral therapy improves ESLD-free survival in HIV-HCV co-infection. Haemophilia (2009) 0.96
Enhanced synthesis and reduced metabolism of endothelin-1 (ET-1) by hepatocytes--an important mechanism of increased endogenous levels of ET-1 in liver cirrhosis. J Hepatol (2000) 0.96
De novo hepatocellular carcinoma in a hepatic allograft with recurrent hepatitis C cirrhosis. Liver Transpl Surg (1999) 0.91
Ex vivo application of carbon monoxide in UW solution prevents transplant-induced renal ischemia/reperfusion injury in pigs. Am J Transplant (2010) 0.91
Microchimerism, GVHD, and tolerance in solid organ transplantation. Transfusion (2001) 0.91
Real-time monitoring of acute liver-allograft rejection using the Banff schema. Transplantation (2002) 0.91
Recurrent hepatitis C in liver allografts: prospective assessment of diagnostic accuracy, identification of pitfalls, and observations about pathogenesis. Am J Surg Pathol (2004) 0.91
Allografts surviving for 26 to 29 years following living-related kidney transplantation: analysis by light microscopy, in situ hybridization for the Y chromosome, and anti-HLA antibodies. Am J Kidney Dis (1994) 0.90
Genotypic analyses of cyclosporine-associated lymphoproliferations. Transplantation (1987) 0.90
Re-examination of the lymphocytotoxic crossmatch in liver transplantation: can C4d stains help in monitoring? Am J Transplant (2011) 0.88
Ex vivo generation of effective Epstein-Barr virus (EBV)-specific CD8+ cytotoxic T lymphocytes from the peripheral blood of immunocompetent Epstein Barr virus-seronegative individuals. Transplantation (2000) 0.86
Detection of infectious baboon cytomegalovirus after baboon-to-human liver xenotransplantation. J Virol (2001) 0.86
Primary pleural effusion posttransplant lymphoproliferative disorder: Distinction from secondary involvement and effusion lymphoma. Diagn Cytopathol (2001) 0.86
Recurrent Epstein-Barr virus-associated lesions in organ transplant recipients. Hum Pathol (1996) 0.85
Sequential analyses of the development of lymphoproliferative disorders in rats receiving cyclosporine. Transplantation (1984) 0.85
Spindle cell tumor of the portal vein. J Surg Oncol (1995) 0.84
ICAM-1 and E-selectin expression in lesional biopsies of psoriasis patients responding to systemic FK 506 therapy. Autoimmunity (1993) 0.83
Concomitant and isolated expression of TGF-alpha and EGF-R in human hepatoma cells supports the hypothesis of autocrine, paracrine, and endocrine growth of human hepatoma. J Surg Oncol (1995) 0.83
Alloimmune hepatitis following peripheral stem cell transplantation. Bone Marrow Transplant (2007) 0.83
Unexpectedly high incidence of Pneumocystis carinii infection after lung-heart transplantation. Implications for lung defense and allograft survival. Am Rev Respir Dis (1988) 0.83
Communication gaps associated with donor-derived infections. Am J Transplant (2014) 0.83
Impact of HIV on liver fibrosis in men with hepatitis C infection and haemophilia. Haemophilia (2010) 0.81
Herpesvirus 6 variant A infection after heart transplantation with giant cell transformation in bile ductular and gastroduodenal epithelium. Am J Surg Pathol (1997) 0.81
Effect of FK 506 on spontaneous diabetes in BB rats. Diabetes (1990) 0.81
Hepatocyte growth factor mRNA in human liver cirrhosis as evidenced by in situ hybridization. Scand J Gastroenterol (1996) 0.81
Primary lymphadenopathic Kaposi's sarcoma in an immunocompetent 23-year-old man. Am J Clin Pathol (1986) 0.79
Combined effects of FK506 (tacrolimus) and cyclophosphamide on atypical B220+ T cells, cytokine gene expression and disease activity in MRL/MpJ-lpr/lpr mice. Clin Exp Immunol (1995) 0.79
Reversal of graft-versus-host disease with infusion of autologous bone marrow. Cell Transplant (1994) 0.79
The potential role of cytokines in the pathogenesis of Epstein-Barr virus associated post-transplant lymphoproliferative disease. Leuk Lymphoma (1994) 0.78
Cancers among US organ donors: a comparison of transplant and cancer registry diagnoses. Am J Transplant (2014) 0.78
Clonal and morphological variation in a posttransplant lymphoproliferative disorder: evolution from clonal T-cell to clonal B-cell predominance. Hum Pathol (1998) 0.78
Suppression of autoimmune thyroid disease by FK 506: influence on thyroid-infiltrating cells, adhesion molecule expression and anti-thyroglobulin antibody production. Clin Exp Immunol (1993) 0.77
FK 506 inhibits cytokine gene and adhesion molecule expression in psoriatic skin lesions. Ann N Y Acad Sci (1993) 0.77
Decreased mucosal IgA levels in ileum of patients with chronic ulcerative colitis. Dig Dis Sci (1995) 0.77
Lymphoepithelial carcinoma of the larynx and hypopharynx: study of eight cases with relationship to Epstein-Barr virus and p53 gene alterations, and review of the literature. Hum Pathol (1996) 0.76
Evidence that small bowel preservation causes primarily basement membrane and endothelial rather than epithelial cell injury. Transplantation (1993) 0.76
Cross-species graft-versus-host-disease is accompanied by a donor-derived cellular immune response. Transplantation (1993) 0.76
Posttransplant lymphoproliferative disease of donor origin. Arch Pathol Lab Med (1997) 0.75
Pathologic analysis of recurrent posttransplant lymphoproliferative disorders. Transplant Proc (1995) 0.75
Immunodulation of intestinal transplantation: antilymphocyte serum donor pretreatment vs. ex vivo graft irradiation. Transplant Proc (2002) 0.75
Quantitative analysis of microchimerism with Y-chromosome-specific PCR in canine small bowel transplantation. Transplant Proc (2000) 0.75
FK 506 modulates D-galactosamine-induced hepatitis in rats. Transplant Proc (1991) 0.75
Effects of immunotherapy on experimental immunodeficiency-related lymphoproliferative disease. Transplantation (1998) 0.75
Epstein-Barr virus-encoded RNA expression as a risk factor for the development of posttransplantation lymphoproliferative disease. Hepatology (1995) 0.75
The surgical implications of the posttransplant lymphoproliferative disorders. Transplant Proc (1991) 0.75
Long-term function and morphology of intestinal allografts in outbred canine transplantation model. Transplant Proc (2002) 0.75
Small bowel preservation causes basement membrane and endothelial cell injury. Transplant Proc (1994) 0.75
Intracranial lipoma with hematopoietic elements (myelolipoma): report of a case with successful surgical resection. Cancer (1982) 0.75
Renal cortical neoplasms in long term survivors of solid organ transplantation. Transplantation (2000) 0.75
Intrathymic transplantation of hepatocytes is facilitated by the addition of pancreatic islets. Transplant Proc (1992) 0.75
Cytologic features of post-transplant lymphoproliferative disorder. Diagn Cytopathol (1997) 0.75
A comparison of indirect immunofluorescence and the avidin-biotin-peroxidase conjugate technic (ABC) in the performance of the antinuclear antibody test. Am J Clin Pathol (1984) 0.75
Quantitative assessment of the development of hepatoma in a buffalo rat model. Transplant Proc (1997) 0.75
Extramedullary hematopoiesis in the allograft liver. Mod Pathol (1995) 0.75
Oxygen free radical formation is related to mucosal injury during reperfusion after rat small bowel transplantation. Transplant Proc (1994) 0.75
A combination study design to examine mycophenolate mofetil (MMF) and PTLD in renal transplant patients. Pharmacoepidemiol Drug Saf (1999) 0.75
Polymorphism and T-cell infiltration in posttransplant lymphoproliferative disorders. Transplant Proc (1999) 0.75
Expression of HGF mRNA in human rejecting kidney as evidenced by in situ hybridization. Urol Res (1996) 0.75
EBER gene expression in Epstein-Barr virus-associated hematopoietic neoplasms. Leuk Lymphoma (1994) 0.75
Intestinal function and morphology after ex vivo irradiated small bowel transplantation. Transplant Proc (2002) 0.75
Occult nonhematopoietic malignancies present at autopsy in solid organ transplant patients who died within 100 days. Transplantation (2001) 0.75
Cross species graft-versus-host disease induces hepatic injury in association with a donor-derived cellular immune response. Transplant Proc (1993) 0.75
Subcutaneous implantation of human post-transplant lymphoproliferative disease lesions in SCID mice. Hematol Oncol (1997) 0.75
Morphologic and immunophenotypic characterization of a cell line derived from liver tissue with Epstein-Barr virus associated post-transplant lymphoproliferative disease. In Vitro Cell Dev Biol Anim (1994) 0.75
Xenogeneic graft-versus-host disease is associated with elevated levels of reactive nitrogen intermediates. Transplant Proc (1992) 0.75